TherapeuticsMD, Inc. (TXMD)

2.22 +0.00% (+0.00)

Over 6M: -0.9%

2026-08-28
Style
Area Line Line with markers Steps Candlesno open/high/low yet Hollow candlesno open/high/low yet Barsno open/high/low yet

Candles need the day’s open, high and low. Those are being collected now — a company shows them once its history has been refreshed.

1.8 2 2.2
Mar Apr May Jun Jul Aug

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '21 — Revenue: 25.4M Q3 '21 — Operating Cash Flow: -38.2M Q3 '21 — Free Cash Flow: -38.3M Q3 '21 — Net Income: -47.4M Q4 '21 — Revenue: 18.7M Q4 '21 — Operating Cash Flow: -39.6M Q4 '21 — Free Cash Flow: -39.6M Q4 '21 — Net Income: -43M Q1 '22 — Revenue: 19.3M Q1 '22 — Operating Cash Flow: -17.9M Q1 '22 — Free Cash Flow: -17.9M Q1 '22 — Net Income: -49M Q2 '22 — Revenue: 28.6M Q2 '22 — Operating Cash Flow: -27.1M Q2 '22 — Free Cash Flow: -27.1M Q2 '22 — Net Income: 112.3M Q3 '22 — Revenue: 354K Q3 '22 — Operating Cash Flow: -18.9M Q3 '22 — Free Cash Flow: -18.9M Q3 '22 — Net Income: -29M Q4 '22 — Revenue: 68.6M Q4 '22 — Operating Cash Flow: 73.2M Q4 '22 — Net Income: 77.7M Q1 '23 — Revenue: 416K Q1 '23 — Operating Cash Flow: -8.7M Q1 '23 — Net Income: -3.6M Q2 '23 — Revenue: 437K Q2 '23 — Operating Cash Flow: -3.4M Q2 '23 — Net Income: -2.4M Q3 '23 — Revenue: -53K Q3 '23 — Operating Cash Flow: -6M Q3 '23 — Net Income: -3.4M Q4 '23 — Revenue: 502K Q4 '23 — Operating Cash Flow: -5M Q4 '23 — Net Income: -883K Q1 '24 — Revenue: 313K Q1 '24 — Operating Cash Flow: -229K Q1 '24 — Net Income: -734K Q2 '24 — Revenue: 234K Q2 '24 — Operating Cash Flow: 1.5M Q2 '24 — Net Income: -1.1M Q3 '24 — Revenue: 547K Q3 '24 — Operating Cash Flow: -71K Q3 '24 — Net Income: -609K Q4 '24 — Revenue: 667K Q4 '24 — Operating Cash Flow: 17K Q4 '24 — Net Income: 252K Q1 '25 — Revenue: 393K Q1 '25 — Operating Cash Flow: 699K Q1 '25 — Net Income: -653K Q2 '25 — Revenue: 952K Q2 '25 — Operating Cash Flow: 381K Q2 '25 — Net Income: 551K Q3 '25 — Revenue: 784K Q3 '25 — Operating Cash Flow: 999K Q3 '25 — Net Income: 152K Q4 '25 — Revenue: 893K Q4 '25 — Operating Cash Flow: 375K Q4 '25 — Net Income: -619K Q1 '26 — Revenue: 724K Q1 '26 — Operating Cash Flow: 944K Q1 '26 — Net Income: 95K Q2 '26 — Revenue: 869K Q2 '26 — Operating Cash Flow: 779K Q2 '26 — Net Income: 155K -35M 0 35M 70M 105M 140M
Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26
Revenue Operating Cash Flow Free Cash Flow Net Income

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

3.8
OE margin 93.0%
Oper. margin -120.9%
ROIC -17.4%
Accruals -8.8%
FCF margin 94.7%
OCF margin 94.7%
Asset turnover 0.087×
EBITDA margin -109.2%
ROA -0.58%
ROCE -12.2%
ROE -0.8%
Capex / sales —
Gross margin —
OCF / EBIT —

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

1.0
RPO / sales —
RPO growth —
Segment HHI —

2 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

6.5
ND/EBITDA —
Interest cover -494.1×
Debt / Eq 0.0×
Debt payback 0.0 yr
Quick ratio 1.9×
F-score 6.4 pts
Cash / Debt —
Cash runway —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

2.3
Sales/sh Y/Y +27.4%
Shares change +0.32%
Sales Q/Q -8.7%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.